Semnur Pharmaceuticals SMNR Cash Flow Statement (2022-2026)

OTC SMNR
$0.30 +0.01 (+3.45%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Semnur Pharmaceuticals Quarterly Cash Flow Statement

Periods 19 quarters
Latest Sep 2026

Semnur Pharmaceuticals reported cash from operations of -$2.22M and free cash flow of -$2.22M for the quarter ended Sep 2026. This cash flow statement covers 19 quarters of results from Mar 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income -0.01M-0.03M0.31M-0.68M-1.01M0.46M0.63M0.55M-1.51M-1.11M-1.30M-0.17M-0.67M-1.00M-152.59M-4.58M-4.35M-3.63M
Share-based CompensationStock Comp. 0.03M0.15M0.09M0.12M140.19M1.48M1.30M0.86M
Gains from Equity InvestmentsGains Equity -0.65M-0.08M
Other non-cash itemsOther Non-Cash 0.01M0.00M0.06M
Change in Working Capital 0.41M0.69M-0.07M-0.64M
Change in Account PayablesChange Payables 0.51M0.50M0.19M
Change in Accrued ExpensesChange Accrued Exp. 0.08M0.01M1.20M1.69M0.36M0.41M0.01M0.05M0.17M0.45M0.33M0.36M
Change in Other Operating AssetsOther Assets Change 0.15M-0.02M-0.04M0.01M-0.05M-0.02M-0.02M0.06M0.00M0.54M0.04M0.05M
Change in Other Operating LiabilitiesOther Liabilities Change 0.01M0.01M0.01M0.02M
Other Working Capital ChangesOther WC Changes -0.15M0.02M0.04M-0.01M0.05M0.03M0.02M-0.05M0.02M-0.54M-0.04M-0.05M
Cash from OperationsCash from Ops. -0.22M-0.04M-0.17M-0.24M-0.16M-0.08M-0.16M-0.37M-0.40M-2.70M-2.11M-2.22M
Investing Activities
Cash from Investing ActivitiesCash from Investing 40.54M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.08M0.03M0.41M0.08M0.35M0.17M1.23M3.50M2.73M2.24M
Long-Term Debt RepaymentsLT Debt Repayment 0.16M0.75M0.66M19.75M
Net Long-Term Debt Issued (Repaid)Net LT Debt 0.08M0.03M-0.16M0.41M0.08M0.35M0.17M1.23M15.15M2.75M2.07M6.18M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.08M0.03M-0.16M0.41M0.08M0.35M0.17M1.23M15.15M2.75M2.07M6.18M
Other financing activities (as filed) -0.06M-1.92M0.00M-0.84M
Cash from Financing ActivitiesCash from Financing 0.02M85.46M-0.08M0.41M0.08M-40.19M0.17M0.39M2.75M2.07M2.24M
Additional items
Change in Cash 0.02M1.09M-0.12M-0.17M-0.24M-0.57M0.00M0.19M-0.20M-0.01M0.08M-0.06M0.02M
Ending Cash Balance 0.02M1.11M0.99M0.82M0.58M0.01M0.01M0.01M0.00M0.00M0.01M0.01M0.01M0.06M0.09M0.02M0.10M0.04M0.05M
Free Cash FlowFCF -0.22M-0.04M-0.17M-0.24M-0.16M-0.08M-0.16M-0.37M-0.40M-2.70M-2.11M-2.22M
Net Cash FlowNCF 0.02M85.24M-0.12M-0.17M-0.24M0.25M0.00M0.19M-0.20M-0.01M0.05M-0.03M0.02M

Semnur Pharmaceuticals Cash Flow Statement API

Pull Semnur Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SMNR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY